2nd Annual
Neuroscience Drug Discovery Congress
29 - 30 July 2020 | CEST (UTC+2)

The Congress will bring together a host of key experts, examining the latest advances in neuroscience research, both in target identification & validation-led approaches

The Neuroscience Drug Discovery Congress includes...

Over 350 discovery delegates as part of the R&D Series EU, representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic & research institutions

Over 20 presentations and case studies focussing on the emerging trends and technological breakthroughs in neuroscience discovery

Discuss the pioneering innovations for in vitro and in vivo disease modelling, as well as future applications of stem cell technologies, including iPS cells

Explore cutting-edge developments in gene therapy for CNS drug discovery and current opportunities for biomarker development in neuroscience

Agenda at a Glance

Day One

  • Drug Discovery for Neurodegenerative Diseases, including for Alzheimer’s, ALS, MS, Parkinson’s, PSP, Huntington’s disease

Day Two

  • Therapeutic Strategies, Enabling Technologies & Biomarker Development

Download Brochure

Full details regarding the Discovery Series: Virtual are available for download in the Conference Brochure